代谢性酸中毒在儿童CKD中常见并与疾病进展相关
本研究基于CKiD前瞻性队列704例3-5期CKD患儿,每6个月监测eGFR和血碳酸氢盐。中位随访3.3年,代谢性酸中毒(血碳酸氢盐<22 mmol/l)在3、4、5期CKD的患病率分别为43%、60%和45%。多变量Cox模型显示,时间变动血碳酸氢盐<18 mmol/l者CKD进展风险显著高于≥22 mmol/l者(aHR 2.44,95%CI 1.43-4.15)。
要点
- 儿童CKD 3-5期代谢性酸中毒患病率高,3、4、5期分别为43%、60%、45%。
- 血碳酸氢盐<18 mmol/l与CKD进展风险增加独立相关(aHR 2.44)。
- 代谢性酸中毒与随访期血清PTH升高相关,但与纵向生长无显著关联。
核心结论
- 代谢性酸中毒是儿童CKD常见并发症,可能为继发性甲状旁腺功能亢进和肾病进展的危险因素。
研究设计与样本
- 前瞻性队列研究,纳入CKiD研究中704例CKD 3-5期患儿,每6个月测量eGFR和血碳酸氢盐。
主要发现
- 基线中位eGFR为27 ml/min/1.73m2,中位血碳酸氢盐为21 mmol/l。
- 中位随访3.3年,代谢性酸中毒(血碳酸氢盐<22 mmol/l)在CKD 3、4、5期的患病率分别为43%、60%、45%。
- 多变量分析中,时间变动代谢性酸中毒与整个随访期log血清甲状旁腺激素显著相关,但与纵向生长无关联。
- 211例患者达到复合终点(ESRD或eGFR下降50%)。
- 多变量Cox模型中,时间变动血碳酸氢盐<18 mmol/l者较≥22 mmol/l者CKD进展风险显著增高(aHR 2.44;95%CI 1.43-4.15)。
临床怎么用
- 对儿童CKD 3-5期患者应监测血碳酸氢盐,关注<18 mmol/l者的CKD进展风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent studies in adult chronic kidney disease (CKD) suggest that metabolic acidosis is associated with faster decline in estimated glomerular filtration rate (eGFR). Alkali therapies improve the course of kidney disease. Here we investigated the prevalence and determinants of abnormal serum bicarbonate values and whether metabolic acidosis may be deleterious to children with CKD. Associations between follow-up serum bicarbonate levels categorized as under 18, 18 to under 22, and 22 or more mmol/l and CKD outcomes in 704 children in the Cardiovascular Comorbidity in Children with CKD Study, a prospective cohort of pediatric patients with CKD stages 3-5, were studied. The eGFR and serum bicarbonate were measured every six months. At baseline, the median eGFR was 27 ml/min/1.73m2 and median serum bicarbonate level 21 mmol/l. During a median follow-up of 3.3 years, the prevalence of metabolic acidosis (serum bicarbonate under 22 mmol/l) was 43%, 60%, and 45% in CKD stages 3, 4, and 5, respectively. In multivariable analysis, the presence of metabolic acidosis as a time-varying covariate was significantly associated with log serum parathyroid hormone through the entire follow-up, but no association with longitudinal growth was found. A total of 211 patients reached the composite endpoint (ESRD or 50% decline in eGFR). In a multivariable Cox model, children with time-varying serum bicarbonate under 18 mmol/l had a significantly higher risk of CKD progression compared to those with a serum bicarbonate of 22 or more mmol/l (adjusted hazard ratio 2.44; 95% confidence interval 1.43-4.15). Thus, metabolic acidosis is a common complication in pediatric patients with CKD and may be a risk factor for secondary hyperparathyroidism and kidney disease progression.
引用
- Harambat J, Kunzmann K, Azukaitis K, et al. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease. Kidney Int. 2017. PMID: 28729033. doi:10.1016/j.kint.2017.05.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。